Interviews

Franck Ueberschlag

Executive Vice President for Product Management

2025-02-25

Jungbunzlauer is a producer of high-quality ingredients derived primarily from natural sources, specifically corn. Our process centers on transforming corn into glucose, which is then fermented to create our portfolio of ingredients. This foundation is key to our business: utilizing natural raw materials and fermentation to ensure sustainability and efficacy.

John Ferris

Executive Vice President, Consumer

Bausch + Lomb

2025-02-25

Digital technology is transforming healthcare, and eye care is no exception. Increased screen usage has contributed to a rise in digital eye strain and dry eye symptoms, creating a greater need for targeted solutions. At Bausch + Lomb, we are exploring ways to help consumers better understand their digital media consumption and its impact on their eye health.

Vaughn DuBow

Senior Director, Product Portfolio Marketing, Health & Wellness and Brad Schwan, Vice President, Marketing

ADM

2025-02-25

The potential here is vast because we now know that the microbiome has connections to almost every aspect of health—what we call the “gut-brain axis,” “gut-skin axis,” and so on.

Nicolas Cartier

CEO

Mérieux Nutrisiences

2025-02-24

For food companies looking to shift from chemical to natural ingredients, we offer services to ensure safety and shelf stability while assessing the environmental impact.

Rob Brewster

CEO

Ingredients by Nature

2025-02-24

Regarding GLP-1, it's not going away—it’s a game-changer that many in the industry recently discovered.

Niels C. Riedemann

CEO

InflaRx N.V.

2025-02-20

InflaRx N.V. is a clinical-stage biopharmaceutical company focused on developing anti-inflammatory therapies by targeting the complement system, specifically C5a, to treat severe immune-mediated diseases.

Michael Kelly

President & CEO

NervGen Pharma Corp.

2025-02-20

NervGen Pharma Corp. is a biotechnology company dedicated to developing innovative treatments to promote nervous system repair in settings of neurotrauma and neurologic disease, with a primary focus on spinal cord injury.

Abigail Buckwalter

CEO

Nestlé Health Science

2025-02-20

I strongly believe that to lead effectively CEOs must also be part cultural anthropologists—constantly observing, engaging, and understanding the industry and consumer behavior. It's not just about the what, but more importantly, the why behind it.

Josh Smiley

President and COO

Zai Lab

2025-02-19

Zai Lab is a global biopharmaceutical company with operations in China and the U.S., focusing on addressing significant unmet needs in the areas of oncology, immunology, neuroscience and infectious disease.

Debbie Hart

President & CEO

BioNJ

2025-02-18

BioNJ is the life sciences trade association for New Jersey dedicated to fostering innovation, supporting companies across the ecosystem, and advocating for policies that benefit patients and the industry.

Pagina 4 din 154